Edwin M. O'Connor

Mr. O’Connor has recently represented:

• argenx NV in its $100 million initial public offering
• Represented the underwriters as joint book-running managers in G1 Therapeutics’ $116 million initial public offering
• Represented the underwriters as joint book-running managers in Ovid Therapeutics’ $75 million initial public offering
• Rodman & Renshaw as the underwriters in BeyondSpring’s $54 million initial public offering
• Represented the underwriters as joint book-running managers in Albireo Pharmas’ $45 million follow-on public offering
• Represented the underwriters in Syndax Pharmaceuticals’ $50 million follow-on public offering
• BeiGene in its $158 million initial public offering and $200 million follow-on public offering
• Represented the underwriters as joint book-running managers in a $40 million follow-on offering for Innocoll
• Represented the underwriters as joint book-running managers in Reata Pharmaceuticals' $60.5 million initial public offering
• Represented the underwriters as joint book-running managers in Oncobiologics' $35 million initial public offering, BeiGene in its $158 million initial public offering
• Voyager Therapeutics in its $70 million initial public offering
• Represented the underwriters as joint book-running managers in the $281.5 million follow-on offering for DBV Technologies
• Represented the underwriters as joint book-running managers in a $162 million secondary public offering by existing shareholders for Horizon Pharma, Inc.
• Inotek Pharmaceuticals Corporation in its $40 million initial public offering and a concurrent offering of $20 million offering of convertible senior notes, its $69 million follow-on offering and its $50 million offering of convertible senior notes
• Represented the underwriters in Trinseo’s $190 million initial public offering*
• Represented the underwriters in Paycom Software’s $100 million initial public offering*

As Vice President in Goldman Sachs’ Investment Banking Division, Mr. O’Connor advised on several initial public offerings, including:

• Cornerstone OnDemand’s $137 million IPO
• RPX’s $160 million IPO
• Gigamon’s $128.5 million IPO
• Jive’s $120 million IPO
• Palo Alto Network’s $260 million IPO

 *Denotes experience prior to joining Goodwin Procter